A new predictive model developed by Ochsner Health helps clinicians make real-time decisions for patients who had a stroke ...

A recent study published in the Stroke; a Journal of Cerebral Circulation found that short-duration dual antiplatelet therapy ...

When the additional factors of age, gender, payer source, and time were included in multivariate models, it was found that age, gender, race, and time were significant predictors of either CEA or CAS.

The study included adult patients (18 years of age or older) undergoing MT for AIS with occlusion of the internal carotid artery (ICA) or M1 segment of the middle cerebral artery with failed first ...

today congratulated the lead investigators on the completion of enrollment in the CREST-2 (Carotid Revascularization Endarterectomy or Stenting Trial) clinical trials. The -Conference call and ...

Carotid artery stenting (CAS) is an alternative treatment for patients with carotid artery stenosis who are not eligible for carotid endarterectomy. Dual antiplatelet therapy (DAPT) after CAS aims to ...

Carotid endarterectomy (CEA) is widely used to treat carotid artery stenosis (CAS). However, the effects of CEA on unilateral CAS‐induced cognitive impairment and the underlying mechanism remain ...

Exclusion criteria were: (1) patients with a history of interventional or surgical treatment, such as carotid artery stenting or carotid endarterectomy; (2) patients with carotid hemangioma or carotid ...

The Medtronic-Contego deal includes the recently FDA-approved Neuroguard IEP 3-in-1 carotid stenting system. Neuroguard IEP delivers a high-performance stent, post-dilation balloon and an ...

Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) was a prospective, multicenter, randomized controlled trial that compared carotid endarterectomy with carotid artery stenting ...